MAA
DGX icon

Managed Account Advisors’s Quest Diagnostics DGX Stock Holding History

Managed Account Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$77M Buy
1,061,417
+14,661
+1% +$1.08M 0.06% 317
2015
Q1 		$80.4M Buy
1,046,756
+74,809
+8% +$5.36M 0.07% 301
2014
Q4 		$65.2M Sell
971,947
-519,039
-35% -$32.8M 0.06% 331
2014
Q3 		$90.5M Buy
1,490,986
+796,146
+115% +$49.1M 0.1% 236
2014
Q2 		$40.8M Buy
694,840
+91,285
+15% +$5.35M 0.05% 416
2014
Q1 		$35M Buy
603,555
+172,526
+40% +$9.25M 0.05% 437
2013
Q4 		$23.1M Buy
431,029
+12,681
+3% +$752K 0.03% 597
2013
Q3 		$25.9M Buy
418,348
+83,715
+25% +$5.01M 0.04% 508
2013
Q2 		$20.3M Buy
+334,633
New +$19.9M 0.03% 563

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Managed Account Advisors's DGX Position: Q2 2015 in Review

Managed Account Advisors increased its Quest Diagnostics (DGX) stake by 1.4% in Q2 2015, buying an estimated $1.08M and bringing the position to 1,061,417 shares worth $77M. The position accounts for 0.06% of the portfolio, ranked #317.

Managed Account Advisors first reported a position in DGX in Q2 2013 and has held it in 9 quarters since. The position peaked at $90.5M in Q3 2014. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

  • Managed Account Advisors held 1,061,417 shares of Quest Diagnostics worth $77M as of Q2 2015.
  • Managed Account Advisors bought 14,661 Quest Diagnostics shares in Q2 2015, an estimated $1.08M.
  • Quest Diagnostics made up 0.06% of Managed Account Advisors's portfolio in Q2 2015, its #317 holding.
  • Managed Account Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Quest Diagnostics position peaked at $90.5M in Q3 2014.
  • 542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.